SPEAKERS
Zhimin (James) Lu
AFFILIATION:
Zhejiang University, Hangzhou, China
POSITION TITLE:
Kuangcheng Wang Distinguished Chair
Director, Cancer Center
Dean, Institute of Translational Medicine
EDUCATION/TRAINING:
Taishan Medical College, Shandong, China, M.D. 1986 Medicine
The Graduate School and University Center, City University of New York, NY,
Ph.D. 1998 Molecular, Cellular and Developmental Biology
Qingdao Hospital, Qingdao, China, 9/1986-1/1992 Physician/Oncologist
The Salk Institute , La Jolla, CA Postdoc 1999-2003 (Mentor: Tony Hunter)
HONORS:
1997 The Beatrice Goldstein Konheim Graduate Scholarship in the Life Sciences, The City University of New York
1999 The Pioneer Fund Fellowship, The Salk Institute
2000 California Breast Cancer Research Program Postdoctoral Fellowship, California Breast Cancer Research Program
2007 Brain Tumor Society Program Award
2008 Peter Steck Memorial Young Investigator Award, Pediatric Brain Tumor Foundation American Cancer Society Research Scholar, American Cancer Society, 2009
2011 The Faculty Scholar Award, The University of Texas MD Anderson Cancer Center
2012 The James S. McDonnell Foundation Scholar Award
2013 The Potu N. Rao Award for Excellence in Basic Science, The University of Texas MD Anderson Cancer Center
2015 The Ruby E. Rutherford Distinguished Professorship, The University of Texas MD Anderson Cancer Center
2015 University of Texas Faculty Science and Technology Acquisition and Retention (STARs) Award, 2015
2016 The Dallas/Fort Worth Living LegendFaculty Achievement Award in Basic Research, The University of Texas MD Anderson Cancer Center
2017 American Association for the Advancement of Science Fellow
2018 Nomination for a member of American Academy of Arts and Sciences
2019 Kuancheng Wang Distinguished Chair, Zhejiang University, China
RESEARCH INTERESTS:
Dr. Lu’s research focusing on cancer signaling and metabolism has made contributions to the cancer metabolism filed by (1) elucidation of instrumental mechanisms of the Warburg effect,
(2) discovery of the protein kinase activity of metabolic enzymes, and (3) revelation of the non-metabolic functions of metabolic enzymes in tumorigenesis.
Dr. Lu’s group milestone discoveries have profoundly affected the understanding of tumor metabolism, and at the same time provided innovative theoretical support for the development of new tumor diagnosis and treatment methods: (1) The first to elucidate molecular mechanism of receptor tyrosine kinase promoting aerobic glycolysis of the Warburg effect; (2) The first time to discover and clarify that a variety of important metabolic enzymes possess protein kinase activity at the same time; (3) For the first time in the world, it is confirmed that a variety of important metabolic enzymes and metabolites in tumors exerting non-metabolic functions in the regulation of cell activity.
PUBLICATIONS:
List of published work in Google Scholar:
https://scholar.google.com/citations?hl=zh-TW&user=7lBK9LkAAAAJ